And further. Novo have built a cosy relationship with Jones over...

  1. 1,206 Posts.
    lightbulb Created with Sketch. 116
    And further. Novo have built a cosy relationship with Jones over the last 3 years (3 Novo related directors now on the CBIO board, 1 of them heavily involved in the licensing agreement 3 years ago while working for Novo).
    Novo have had a free ride during this time with CBIO shareholders picking up the tab. If they want the drug they have to pay for it, simple as that. Jones's position is untenable.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.